-
GenOptima Launches Results-as-a-Service GEO Infrastructure to Help Enterprises Ensure Outcome in AI Search
SHANGHAI, July 16, 2026 (GLOBE NEWSWIRE) — GenOptima, an enterprise Generative Engine Optimization (GEO) infrastructure provider, announced the launch of its Results-as-a-Service (RaaS)-based GEO solution, designed to help organizations ensure outcome through measurable AI search visibility management as AI-powered search platforms continue to reshape how brands are discovered, interpreted, and recommended. GenOptima — Brand Consensus…
-
NTG Nordic Transport Group A/S – H1 2026 Conference Call
July 09, 2026 04:00 ET | Source: NTG Nordic Transport Group A/S NTG Nordic Transport Group A/S – H1 2026 Conference Call We expect to release the H1 2026 interim results of NTG Nordic Transport Group on the evening of August 10, 2026. A webcast and conference call will be held in the morning of…
-
Mach Travel Solutions Limited to Voluntarily Publish Quarterly Financial Results
NEW DELHI, July 3, 2026 /PRNewswire/ — Mach Travel Solutions Limited (BSE: MACHLTD), a publicly listed technology-enabled travel solutions company, will voluntarily publish its quarterly financial results commencing from Q1 FY27, despite being listed on the BSE SME Platform, where publication of financial results on a half-yearly basis is the prescribed regulatory requirement. The decision…
-
Parimatch Sports Launches "Inside the Game" YouTube Show, Kicking Off with Ritu Phogat
Parimatch Sports, a high-quality sportswear brand inspired by the world’s top athletes, has launched its new YouTube show, “Inside the Game” – a series that goes beyond results and achievements to uncover the people behind the athletes. Each episode combines candid conversations with competitions, games and challenges, giving guests the opportunity to answer unconventional questions and reveal…
-
POET Technologies Recaps Highlights of CEO’s Update on Commercial Activities and Provides Results of 2026 AGM
TORONTO, June 30, 2026 (GLOBE NEWSWIRE) — POET Technologies Inc. (“POET” or the “Company”) (NASDAQ: POET), the designer and developer of Photonic Integrated Circuits (PICs), light sources and optical modules for the AI and data center markets, today reported the voting results of its Annual General Meeting (the “AGM”), which was held virtually on Friday,…
-
Press Release: Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study
Sanofi’s Nexviazyme met all primary and secondary endpoints in infantile-onset Pompe disease phase 3 study Nexviazyme met its primary endpoint, participants alive and free of invasive ventilation, in treatment-naïve infants zero to six months of age in the Baby-COMET phase 3 study Sanofi intends to submit the data to support a regulatory application in the…
-
MoonLake Announces Week 52 Results of Sonelokimab from its Phase 3 VELA Program in Hidradenitis Suppurativa and Confirms Investor Day on June 22, 2026
Results from the Phase 3 VELA clinical trials at Week 52 in adults with moderate-to-severe hidradenitis suppurativa (HS) demonstrate sonelokimab’s (SLK) potential best-in-class and best-in-disease profile, with consistent responses that are higher than those observed in trials of competing agents at the end of their respective parental trials Namely, ~67% of patients treated with SLK…
-
Akums Reports Q2 FY26 Results; Strengthens International Presence
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the second quarter of FY26. The CDMO segment remained the key contributor with revenue of Rs. 804 crore. Volumes for the CDMO vertical grew 7% y-o-y, as against muted industry volume growth, reflecting…
-
Press Release: Sanofi launches 2026 global employee stock purchase plan
Sanofi launches 2026 global employee stock purchase plan Paris, June 4, 2026. Sanofi’s global employee shareholder plan, Action 2026, opens on June 9, 2026, to around 75,000 employees in 52 countries. Now in its 12th year, the program demonstrates the ongoing commitment of Sanofi and its Board of Directors to involve employees in the company’s…
-
Akums Delivers Strong Q3 FY26 Performance with 14.8% Revenue Growth and 21% Adj EBITDA Growth
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s Largest Contract Development and Manufacturing Organizations (CDMO), announced its financial results for the third quarter of FY26. Q3 FY 26 saw strong performance across its key business segments. CDMO saw a revenue growth of over 16% spurred on by double digit increase in volumes. The…
-
Akums Reports Q4 FY26 and Full Year FY26 Results with Healthy Top Line and Strong EBITDA Growth; Board Recommends Dividend
New Delhi, Delhi, India Akums Drugs & Pharmaceuticals Ltd., India’s largest Contract Development and Manufacturing Organisation (CDMO), announced its financial results for the fourth quarter and the full year ended March 31, 2026. The company delivered a steady performance during Q4 FY26, with healthy revenue growth and improved operating profitability driven by its core domestic…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
